Progress towards global polio eradication.
暂无分享,去创建一个
[1] P. Parkman. An assessment of the safety and efficacy implications of removing the type 2 strain from the trivalent oral poliovirus vaccine , 1997 .
[2] J. Kratzer,et al. Outside Europe. Is poliomyelitis a serious problem in developing countries?--the Danfa experience. , 1977, British medical journal.
[3] Y. Manor,et al. Detection of Poliovirus Circulation by Environmental Surveillance in the Absence of Clinical Cases in Israel and the Palestinian Authority , 1999, Journal of Clinical Microbiology.
[4] L. Davis,et al. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. , 1977, The New England journal of medicine.
[5] M. Pallansch,et al. Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient , 1998, Journal of Clinical Microbiology.
[6] S. Robertson,et al. Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. , 1994, Bulletin of the World Health Organization.
[7] John Tj,et al. Is poliomyelitis a serious problem in developing countries? The Vellore experience. , 1982 .
[8] H. Hull,et al. Paralytic poliomyelitis: seasoned strategies, disappearing disease , 1994, The Lancet.
[9] Ochoa Eg,et al. Epidemiological surveillance and control of poliomyelitis in the Republic of Cuba. , 1987 .
[10] M. Otten,et al. Massive outbreak of poliomyelitis caused by type-3 wild poliovirus in Angola in 1999. , 2000, Bulletin of the World Health Organization.
[11] D. Rowland,et al. Statistical certification of eradication of poliomyelitis in the Americas. , 1998, Mathematical biosciences.
[12] T. John. Antibody response of infants in tropics to five doses of oral polio vaccine. , 1976, British medical journal.
[13] P E Fine,et al. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. , 1999, American journal of epidemiology.
[14] H. Hull,et al. National immunization days: state of the art. , 1997, The Journal of infectious diseases.
[15] P. Wright,et al. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. , 1991, Reviews of infectious diseases.
[16] J. Foulds,et al. Global eradication of poliomyelitis: benefit-cost analysis. , 1996, Bulletin of the World Health Organization.